KRT7 and pancreatic adenocarcinoma: The CK7+/CK20+ immunophenotype, on the other hand, was observed in 20% of colon, 48% of gastric, and 22% of pancreatic adenocarcinomas, which is the immunophenotype observed in our renal pelvis mucinous adenocarcinoma.